Viewing nowCombinationEmpamax S Tablet 25/100 mg (Empagliflozin, Sitagliptin)
Sitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 31.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202500821 · Approved 2025.04.07 · Insurance code 643309790
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps adults with type 2 diabetes control their blood sugar by using empagliflozin and sitagliptin together. It is used to effectively manage blood sugar when combined with diet and exercise.
The recommended starting dose of this medicine is empagliflozin 10 mg/sitagliptin 100 mg once daily. If the patient tolerates empagliflozin 10 mg/sitagliptin 100 mg but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg/sitagliptin 100 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and sitagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. Do not take a double dose in one day. Special populations Patients with renal impairment Because the efficacy and safety of this medicine vary according to renal function, it is recommended that renal function be assessed before treatment and periodically thereafter. No dose adjustment is required in patients with mild renal impairment [creatinine clearance (CrCl) glycemic control ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. Do not administer this medicine if creatinine clearance (CrCl) is less than 45 ml/min or estimated glomerular filtration rate (eGFR) is less than 45 ml/min/1.73m2. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population.
This medication may cause allergic reactions, so it should not be used in patients who have had a hypersensitivity reaction to this drug or its components in the past. During treatment with this medication, serious side effects such as acute pancreatitis may occur, so if symptoms such as abdominal pain, vomiting, or loss of appetite appear, consult a doctor immediately. Patients with decreased kidney function may experience reduced effectiveness of this drug and should take it with caution while regularly monitoring kidney function. This drug may cause hypoglycemia, so when taken with insulin or other antihyperglycemic agents, blood sugar levels should be monitored often to avoid symptoms of hypoglycemia. The risk of genital infections and urinary tract infections may increase, so prompt treatment should be received if infection symptoms occur. Symptoms of low blood pressure or dehydration due to decreased fluid volume may occur, so caution is needed, especially in older adults or those with low blood pressure. Use of this drug during pregnancy or breastfeeding is not recommended, and consultation with a doctor is essential before taking it. Safety and efficacy have not been established for children and adolescents under 18, so it should not be used in these populations. In case of an overdose, visit a medical institution immediately for appropriate treatment, as it may not be easily removed by dialysis. During treatment, caution is needed when driving or operating machinery due to the risk of accidents from hypoglycemia. If unusual symptoms such as fever, pain, or swelling occur while taking this medication, notify a doctor immediately and seek treatment.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the efficacy and safety of the medication.
Pale yellow-pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 31.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 128.5mg · Empagliflozin L-Proline 12.55mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.